Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials

Autor: Fallah, Jaleh *, Zhang, Lijun, Amatya, Anup, Gong, Yutao, King-Kallimanis, Bellinda, Bhatnagar, Vishal, Weinstock, Chana, Suzman, Daniel L, Agrawal, Sundeep, Chang, Elaine, Anscher, Mitchell S, Chi, Dow-Chung, Xu, James X, Brewer, Jamie R, Brave, Michael H, Hadadi, Mehrnoosh, Theoret, Marc R, Kluetz, Paul G, Goldberg, Kirsten B, Ibrahim, Amna, Tang, Shenghui, Pazdur, Richard, Beaver, Julia A, Amiri-Kordestani, Laleh, Singh, Harpreet
Zdroj: In The Lancet Oncology September 2021 22(9):1230-1239
Databáze: ScienceDirect